{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:22:53Z","timestamp":1789122173209,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phymed.2024.155598","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:39:32Z","timestamp":1712439572000},"page":"155598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of natural extract interventions in prostate cancer: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"129","author":[{"given":"Haotian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-3788","authenticated-orcid":false,"given":"Xuesong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155598_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00441-003-0763-8","article-title":"Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk","volume":"314","author":"Acker","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.phymed.2024.155598_bib0002","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-06-2269","article-title":"Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo","volume":"13","author":"Adhami","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155598_bib0003","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/carcin\/bgm042","article-title":"Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells","volume":"28","author":"Agarwal","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155598_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071792","article-title":"Effects on serum hormone concentrations after a dietary phytoestrogen intervention in patients with prostate cancer: a randomized controlled trial","volume":"15","author":"Ahlin","year":"2023","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2024.155598_bib0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1055-9965.EPI-06-1062","article-title":"Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition","volume":"16","author":"Allen","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.phymed.2024.155598_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pca.3304","article-title":"Hydrogen-rich solvent method in phytochemical extraction: potential mechanisms and perspectives","volume":"35","author":"Alwazeer","year":"2024","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.phymed.2024.155598_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J077v26n02_02","article-title":"Quality of life of men with biochemical recurrence of prostate cancer","volume":"26","author":"Ames","year":"2008","journal-title":"J. Psychosoc. Oncol."},{"key":"10.1016\/j.phymed.2024.155598_bib0008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1464-410X.2003.04370.x","article-title":"A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer","volume":"92","author":"Ansari","year":"2003","journal-title":"BJu Int."},{"key":"10.1016\/j.phymed.2024.155598_bib0009","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1940-6207.CAPR-18-0147","article-title":"Prodiet: a Phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer","volume":"11","author":"Athene Lane","year":"2018","journal-title":"Cancer Prev. Res. (Phila Pa)"},{"key":"10.1016\/j.phymed.2024.155598_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3835(99)00276-1","article-title":"Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin","volume":"147","author":"Bhatia","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155598_bib0011","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/01635581.2020.1870706","article-title":"Impact of 18-month soy protein supplementation on steroid hormones and serum biomarkers of angiogenesis, apoptosis, and the growth Hormone\/IGF-1 Axis: results of a randomized, placebo-controlled trial in males following prostatectomy","volume":"74","author":"Bosland","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/01635581.2021.1903949","article-title":"Randomized, placebo-controlled six-month intervention study of soy protein isolate in men with biochemical recurrence after radical prostatectomy: a pilot study","volume":"74","author":"Bosland","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0013","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/pros.23389","article-title":"Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery","volume":"77","author":"Breen","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10408398.2012.680205","article-title":"Green tea and anticancer perspectives: updates from last decade","volume":"55","author":"Butt","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.phymed.2024.155598_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051261","article-title":"IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer","volume":"9","author":"Cai","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2024.155598_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-10-258","article-title":"Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4","volume":"10","author":"Cervi","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0017","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.phymed.2024.155598_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10552-010-9684-5","article-title":"Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer","volume":"22","author":"Chan","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.phymed.2024.155598_bib0019","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1097\/MD.0000000000001260","article-title":"Lycopene and risk of prostate cancer: a systematic review and meta-analysis","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.phymed.2024.155598_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2018.02.025","article-title":"Prostate cancer chemoprevention by natural agents: clinical evidence and potential implications","volume":"422","author":"Chhabra","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155598_bib0021","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/pros.23766","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation","volume":"79","author":"Choi","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0022","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1158\/1535-7163.MCT-05-0389","article-title":"Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer","volume":"5","author":"Chun","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2024.155598_bib0023","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1940-6207.CAPR-14-0459","article-title":"Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy","volume":"8","author":"Cipolla","year":"2015","journal-title":"Cancer Prev. Res. (Phila Pa)"},{"key":"10.1016\/j.phymed.2024.155598_bib0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0303-7207(98)00024-0","article-title":"Role of insulin-like growth factor binding proteins in controlling IGF actions","volume":"140","author":"Clemmons","year":"1998","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.phymed.2024.155598_bib0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.urology.2004.04.009","article-title":"Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer","volume":"64","author":"Dalais","year":"2004","journal-title":"Urology."},{"key":"10.1016\/j.phymed.2024.155598_bib0026","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd917","article-title":"Structural biology of insulin and IGF1 receptors: implications for drug design","volume":"1","author":"De Meyts","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155598_bib0027","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1158\/1055-9965.EPI-08-0008","article-title":"Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men Presurgery","volume":"17","author":"Demark-Wahnefried","year":"2008","journal-title":"Cancer Epidemiol. Biomarker. Prevent."},{"key":"10.1016\/j.phymed.2024.155598_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/01635580701308034","article-title":"Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the prostate cancer lifestyle trial","volume":"58","author":"Dewell","year":"2007","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0029","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jsfa.11404","article-title":"Ultrasound-assisted extraction of oil from hempseed (Cannabis sativa L.): part 1","volume":"102","author":"Esposito","year":"2022","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.phymed.2024.155598_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","journal-title":"Trends. Cell Biol."},{"key":"10.1016\/j.phymed.2024.155598_bib0031","article-title":"Green tea (Camellia sinensis) for the prevention of cancer","volume":"3","author":"Filippini","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phymed.2024.155598_bib0032","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/pros.21118","article-title":"A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer","volume":"70","author":"Flaig","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0033","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ijrobp.2013.04.043","article-title":"Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy","volume":"86","author":"Freedland","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.phymed.2024.155598_bib0034","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2012.8265","article-title":"Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial","volume":"308","author":"Fried","year":"2012","journal-title":"JAMaJAMa"},{"key":"10.1016\/j.phymed.2024.155598_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/CEJ.0000000000000189","article-title":"Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy","volume":"25","author":"Gee","year":"2016","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.phymed.2024.155598_bib0036","doi-asserted-by":"crossref","first-page":"e6426","DOI":"10.1097\/MD.0000000000006426","article-title":"Green tea and the risk of prostate cancer: a systematic review and meta-analysis","volume":"96","author":"Guo","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.phymed.2024.155598_bib0037","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/taap.1999.8885","article-title":"Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells","volume":"164","author":"Gupta","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155598_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212530","article-title":"FOXO3a and its regulators in prostate cancer","volume":"22","author":"Habrowska-G\u00f3rczy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155598_bib0039","doi-asserted-by":"crossref","first-page":"e68331","DOI":"10.1371\/journal.pone.0068331","article-title":"Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial","volume":"8","author":"Hamilton-Reeves","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155598_bib0040","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/S0022-5347(01)63309-3","article-title":"Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study","volume":"159","author":"Hampel","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.phymed.2024.155598_bib0041","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2011.04.004","article-title":"Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-\u03baB signaling","volume":"307","author":"Han","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155598_bib0042","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","article-title":"Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study","volume":"68","author":"Hejazi","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0043","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/pros.22943","article-title":"Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy","volume":"75","author":"Henning","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0044","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2024.155598_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.phymed.2024.155598_bib0046","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.3390\/ijms140714620","article-title":". The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence","volume":"14","author":"Holzapfel","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155598_bib0047","article-title":"Lycopene for the prevention of prostate cancer","volume":"2011","author":"Ilic","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phymed.2024.155598_bib0048","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clnu.2007.01.002","article-title":"Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines","volume":"26","author":"Ivanov","year":"2007","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.phymed.2024.155598_bib0049","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/sim.4172","article-title":"Multivariate meta-analysis: potential and promise","volume":"30","author":"Jackson","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.phymed.2024.155598_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.24076","article-title":"A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance","volume":"81","author":"Jarrard","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0051","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1207\/s15327914nc4701_5","article-title":"Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma","volume":"47","author":"Kim","year":"2003","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0052","first-page":"861","article-title":"Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy","volume":"10","author":"Kucuk","year":"2001","journal-title":"Cancer Epidemiol. Biomarker. Prevent."},{"key":"10.1016\/j.phymed.2024.155598_bib0053","first-page":"1","article-title":"Results of a randomized clinical trial of the action of several doses of lycopene in localized prostate cancer: administration prior to radical prostatectomy","volume":"1","author":"Kumar","year":"2008","journal-title":"Clin. Med. Urol."},{"key":"10.1016\/j.phymed.2024.155598_bib0054","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pros.10362","article-title":"The specific role of isoflavones in reducing prostate cancer risk","volume":"59","author":"Kumar","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0055","first-page":"3","article-title":"Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy","volume":"8","author":"Kumar","year":"2010","journal-title":"J. Soc. Integr. Oncol."},{"key":"10.1016\/j.phymed.2024.155598_bib0056","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.18632\/oncotarget.27529","article-title":"A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy","volume":"11","author":"Kumar","year":"2020","journal-title":"Oncotarget."},{"key":"10.1016\/j.phymed.2024.155598_bib0057","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/01635581.2011.582221","article-title":"Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial","volume":"63","author":"Lazarevic","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0058","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jama.2009.1348","article-title":"Outcomes of localized prostate cancer following conservative management","volume":"302","author":"Lu-Yao","year":"2009","journal-title":"JAMa"},{"key":"10.1016\/j.phymed.2024.155598_bib0059","doi-asserted-by":"crossref","first-page":"e78479","DOI":"10.1371\/journal.pone.0078479","article-title":"Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor","volume":"8","author":"Mahmoud","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155598_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/1940-6207.CAPR-08-0167","volume":"2","author":"McLarty","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.phymed.2024.155598_bib0061","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/10781552211006182","article-title":"Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: a randomized, triple blind, placebo-controlled clinical trial","volume":"28","author":"Moezian","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.phymed.2024.155598_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.phymed.2024.155598_bib0063","article-title":"Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial","volume":"14","author":"Navarro","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155598_bib0064","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1940-6207.CAPR-11-0306","article-title":"Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities","volume":"5","author":"Nguyen","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.phymed.2024.155598_bib0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clnu.2016.06.014","article-title":"Tomato-based randomized controlled trial in prostate cancer patients: effect on PSA","volume":"36","author":"Paur","year":"2017","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.phymed.2024.155598_bib0066","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0067","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nbt1289","article-title":"An integrated mass spectrometric and computational framework for the analysis of protein interaction networks","volume":"25","author":"Rinner","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phymed.2024.155598_bib0068","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phymed.2024.155598_bib0069","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.phymed.2024.155598_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2024.155598_bib0071","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/carcin\/bgm218","article-title":"Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft","volume":"28","author":"Singh","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155598_bib0072","first-page":"3063","article-title":"Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels","volume":"62","author":"Singh","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155598_bib0073","first-page":"933","article-title":"Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis","volume":"12","author":"Singh","year":"2003","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.phymed.2024.155598_bib0074","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ijc.26141","article-title":"Methylseleninic acid downregulates hypoxia-inducible factor-1\u03b1 in invasive prostate cancer","volume":"130","author":"Sinha","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ. J. Surg."},{"key":"10.1016\/j.phymed.2024.155598_bib0076","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.lfs.2006.07.036","article-title":"Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer","volume":"79","author":"Stuart","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155598_bib0077","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5507\/bp.2016.056","article-title":"Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings","volume":"160","author":"Student","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub."},{"key":"10.1016\/j.phymed.2024.155598_bib0078","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.24710","article-title":"Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha\/VEGF signaling pathways in human breast cancer cells","volume":"126","author":"Tang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01635580701413934","article-title":"Lycopene and soy isoflavones in the treatment of prostate cancer","volume":"59","author":"Vaishampayan","year":"2007","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0080","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1111\/bju.12435","article-title":"Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"113","author":"van Die","year":"2014","journal-title":"BJu Int."},{"key":"10.1016\/j.phymed.2024.155598_bib0081","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pros.23317","article-title":"A placebo-controlled double-blinded randomized pilot study of combination phytotherapy in biochemically recurrent prostate cancer","volume":"77","author":"van Die","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0082","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejca.2008.02.020","article-title":"Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels","volume":"44","author":"Verschoyle","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155598_bib0083","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5507\/bp.2010.036","article-title":"The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial","volume":"154","author":"Vidlar","year":"2010","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub."},{"key":"10.1016\/j.phymed.2024.155598_bib0084","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/jn\/133.7.2367","article-title":"Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase","volume":"133","author":"Wang","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.phymed.2024.155598_bib0085","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1210\/mend-2-12-1176","article-title":"Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein","volume":"2","author":"Wood","year":"1988","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phymed.2024.155598_bib0086","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.5740\/jaoacint.17-0232","article-title":"Supercritical fluid extraction of bioactive compounds from plant materials","volume":"100","author":"Wrona","year":"2017","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.phymed.2024.155598_bib0087","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pros.23160","article-title":"Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis","volume":"76","author":"Xie","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.phymed.2024.155598_bib0088","doi-asserted-by":"crossref","first-page":"C954","DOI":"10.1152\/ajpcell.00598.2008","article-title":"Perspectives in mammalian IGFBP-3 biology: local vs. systemic action","volume":"296","author":"Yamada","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T23:54:29Z","timestamp":1717286069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":88,"alternative-id":["S0944711324002630"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155598","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of natural extract interventions in prostate cancer: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155598"}}